Epigenetics Components of Aging in the Central Nervous System

Neurotherapeutics

Volumn 10, Issue 4, 2013, Pages 647-663

  Zhao, Yue Qiang ^a,b   Jordan, I King ^c,d   Lunyak, Victoria V ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d PanAmerican Bioinformatics Institute   (Colombia)

Author keywords

aging; chromatin; CNS; DNA methylation; Epigenetics; HDAC; histone code; neurodegeneration

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DAXX PROTEIN; DNA METHYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H3;

AGING; CELL DIFFERENTIATION; CELL TYPE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; CHROMATIN; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HISTONE PHOSPHORYLATION; HUMAN; INTRACELLULAR SIGNALING; NERVE CELL; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

AGING; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; EPIGENESIS, GENETIC; HUMANS; MEMORY;

EID: 84886240487     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-013-0229-y     Document Type: Review

References (143)

1. Waddington CH. The strategy of the genes; a discussion of some aspects of theoretical biology. Allen & Unwin, London, 1957.
2. Waterland RA, Jirtle RL. Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23: 5293-5300.
3. Weaver IC, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004;7: 847-854.
4. Qureshi IA, Mehler MF. Long non-coding RNAs: Novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics 2013.
5. Tang B, Chang WL, Lanigan CM, Dean B, Sutcliffe JG, Thomas EA. Normal human aging and early-stage schizophrenia share common molecular profiles. Aging Cell 2009;8: 339-342.
6. Narayan P, Dragunow M: Pharmacology of epigenetics in brain disorders. British journal of pharmacology (2010) 159(2): 285-303.
7. Tollervey JR, Lunyak VV. Epigenetics: Judge, jury and executioner of stem cell fate. Epigenetics 2012;7: 823-840.
8. Delatte B, Fuks F. Tet proteins: On the frenetic hunt for new cytosine modifications. Brief Funct Genomics 2013;12: 191-204.
9. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992;69: 915-926.
10. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases DNMT3a and DNMT3b are essential for de novo methylation and mammalian development. Cell 1999;99: 247-257.
11. Wu H, Coskun V, Tao J, et al. DNMT3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 2010;329: 444-448.
12. Feng J, Zhou Y, Campbell SL, et al. Dnmt1 and dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 2010;13: 423-430.
13. Miller CA, Gavin CF, White JA, et al. Cortical DNA methylation maintains remote memory. Nat Neurosci 2010;13: 664-666.
14. Amir RE, van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in x-linked mecp2, encoding methyl-CPG-binding protein 2. Nat Genet 1999;23: 185-188.
15. Lunyak VV, Burgess R, Prefontaine GG, et al. Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 2002;298: 1747-1752.
16. Szulwach KE, Li X, Li Y, et al. 5-hmc-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci 2011;14: 1607-1616.
17. Wang T, Pan Q, Lin L, et al. Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum. Hum Mol Genet 2012;21: 5500-5510.
18. Numata S, Ye T, Hyde TM, et al. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet 2012;90: 260-272.
19. Stadler F, Kolb G, Rubusch L, et al. Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain. J Neurochem 2005;94: 324-336.
20. Cheung I, Shulha HP, Jiang Y, et al. Developmental regulation and individual differences of neuronal h3k4me3 epigenomes in the prefrontal cortex. Proc Natl Acad Sci U S A 2010;107: 8824-8829.
21. Wang CM, Tsai SN, Yew TW, Kwan YW, Ngai SM. Identification of histone methylation multiplicities patterns in the brain of senescence-accelerated prone mouse 8. Biogerontology 2010;11: 87-102.
22. Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004;429: 883-891.
23. Jakovcevski M, Akbarian S. Epigenetic mechanisms in neurological disease. Nat Med 2012;18: 1194-1204.
24. Peleg S, Sananbenesi F, Zovoilis A, et al. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010;328: 753-756.
25. Fischer A, Sananbenesi F, Mungenast A, Tsai LH. Targeting the correct hdac(s) to treat cognitive disorders. Trends Pharmacol Sci 2010;31: 605-617.
26. Erraji-Benchekroun L, Underwood MD, Arango V, et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry 2005;57: 549-558.
27. Copray S, Huynh JL, Sher F, Casaccia-Bonnefil P, Boddeke E. Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging. Glia 2009;57: 1579-1587.
28. Ginsberg SD. Expression profile analysis of brain aging. In: Riddle DR (ed.) Brain aging: Models, methods, and mechanisms. CRS press. Boca Raton, FL, 2007, chaper 7, pp: 159-189.
29. Patterton D, Wolffe AP. Developmental roles for chromatin and chromosomal structure. Dev Biol 1996;173: 2-13.
30. Bonisch C, Hake SB. Histone H2A variants in nucleosomes and chromatin: More or less stable? Nucleic Acids Res 2012;40: 10719-10741.
31. Michod D, Bartesaghi S, Khelifi A, et al. Calcium-dependent dephosphorylation of the histone chaperone daxx regulates h3. 3 loading and transcription upon neuronal activation. Neuron 2012;74: 122-135.
32. Fernando RN, Eleuteri B, Abdelhady S, Nussenzweig A, Andang M, Ernfors P. Cell cycle restriction by histone h2ax limits proliferation of adult neural stem cells. Proc Natl Acad Sci U S A 2011;108: 5837-5842.
33. Scaturro M, Nastasi T, Raimondi L, Bellafiore M, Cestelli A, Di Liegro I. H1(0) rna-binding proteins specifically expressed in the rat brain. J Biol Chem 1998;273: 22788-22791.
34. Lindner H, Sarg B, Hoertnagl B, Helliger W. The microheterogeneity of the mammalian h1(0) histone. Evidence for an age-dependent deamidation. J Biol Chem 1998;273: 13324-13330.
35. Brown DT, Alexander BT, Sittman DB. Differential effect of h1 variant overexpression on cell cycle progression and gene expression. Nucleic Acids Res 1996;24: 486-493.
36. Bantignies F, Cavalli G. Cellular memory and dynamic regulation of polycomb group proteins. Curr Opin Cell Biol 2006;18: 275-283.
37. Heard E, Rougeulle C, Arnaud D, Avner P, Allis CD, Spector DL. Methylation of histone H3 at lys-9 is an early mark on the x chromosome during X inactivation. Cell 2001;107: 727-738.
38. McKinnon PJ. Ataxia telangiectasia: New neurons and ATM. Trends Mol Med 2001;7: 233-234.
39. Hon GC, Rajagopal N, Shen Y, et al. Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat Genet 2013; 45: 1198-1206.
40. Santoro SW, Dulac C. The activity-dependent histone variant h2be modulates the life span of olfactory neurons. eLife 2012;1: e00070.
41. Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Develop 2006;20: 1405-1428.
42. Edelman LB, Fraser P. Transcription factories: Genetic programming in three dimensions. Curr Opin Genet Dev 2012;22: 110-114.
43. Lanctot C, Cheutin T, Cremer M, Cavalli G, Cremer T. Dynamic genome architecture in the nuclear space: Regulation of gene expression in three dimensions. Nat Rev Genet 2007;8: 104-115.
44. Sutherland H, Bickmore WA. Transcription factories: Gene expression in unions? Nat Rev Genet 2009;10: 457-466.
45. Xu M, Cook PR. The role of specialized transcription factories in chromosome pairing. Biochim Biophys Acta 2008;1783: 2155-2160.
46. Pina B and Suau P. Core histone variants and ubiquitinated histones 2a and 2b of rat cerebral cortex neurons. Biochem Biophys Res Commun 1985;133: 505-510.
47. Duce JA, Smith DP, Blake RE, et al. Linker histone h1 binds to disease associated amyloid-like fibrils. J Mol Biol 2006;361: 493-505.
48. Thakar A, Gupta P, Ishibashi T, et al. H2a. Z and h3. 3 histone variants affect nucleosome structure: Biochemical and biophysical studies. Biochemistry 2009;48: 10852-10857.
49. Jin C, Felsenfeld G. Nucleosome stability mediated by histone variants h3. 3 and h2a. Z. Genes Develop 2007;21: 1519-1529.
50. Crepaldi L, Policarpi C, Coatti A, et al. Binding of tfiiic to sine elements controls the relocation of activity-dependent neuronal genes to transcription factories. PLoS Genet 2013;9: e1003699.
51. Lunyak VV, Atallah M. Genomic relationship between sine retrotransposons, pol iii-pol ii transcription, and chromatin organization: The journey from junk to jewel. Biochem Cell Biol 2011; 89: 495-504.
52. Lunyak VV. Boundaries. Boundaries.Boundaries??? Curr Opin Cell Biol 2008;20: 281-287.
53. Wang J, Geesman GJ, Hostikka SL, et al. Inhibition of activated pericentromeric sine/alu repeat transcription in senescent human adult stem cells reinstates self-renewal. Cell Cycle 2011;10: 3016-3030.
54. De Cecco M, Criscione SW, Peckham EJ, et al. Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell 2013;12: 247-256.
55. Lunyak VV, Prefontaine GG, Nunez E, et al: Developmentally regulated activation of a sine b2 repeat as a domain boundary in organogenesis. Science 2007;317: 248-251.
56. Hu Q, Kwon YS, Nunez E, et al. Enhancing nuclear receptor-induced transcription requires nuclear motor and lsd1-dependent gene networking in interchromatin granules. Proc Natl Acad Sci U S A 2008;105: 19199-19204.
57. Surani MA. Reprogramming of genome function through epigenetic inheritance. Nature 2001;414: 122-128.
58. Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 2006;10: 105-116.
59. Solovei I, Grandi N, Knoth R, Folk B, Cremer T. Positional changes of pericentromeric heterochromatin and nucleoli in postmitotic Purkinje cells during murine cerebellum development. Cytogenet Genome Res 2004;105: 302-310.
60. Bosch A, Suau P. Changes in core histone variant composition in differentiating neurons: The roles of differential turnover and synthesis rates. Eur J Cell Biol 1995;68: 220-225.
61. Fontebasso AM, Liu XY, Sturm D, Jabado N. Chromatin remodeling defects in pediatric and young adult glioblastoma: A tale of a variant histone 3 tail. Brain Pathol 2013;23: 210-216.
62. Wan LB, Bartolomei MS. Regulation of imprinting in clusters: Noncoding rnas versus insulators. Adv Genet 2008;61: 207-223.
63. Tyler JK. Chromatin assembly. Cooperation between histone chaperones and atp-dependent nucleosome remodeling machines. Eur J Biochem 2002;269: 2268-2274.
64. Ransom M, Dennehey BK, Tyler JK. Chaperoning histones during DNA replication and repair. Cell 2010;140: 183-195.
65. Lopez MF, Tollervey J, Krastins B, et al. Depletion of nuclear histone h2a variants is associated with chronic DNA damage signaling upon drug-evoked senescence of human somatic cells. Aging 2012;4: 823-842.
66. O'Sullivan RJ, Kubicek S, Schreiber SL, Karlseder J. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat Struct Mol Biol 2010;17: 1218-1225.
67. Das C, Tyler JK, Churchill ME. The histone shuffle: Histone chaperones in an energetic dance. Trends Biochem Sci 2010;35: 476-489.
68. Itoh T, Ausio J, Katagiri C. Histone h1 variants as sperm-specific nuclear proteins of rana catesbeiana, and their role in maintaining a unique condensed state of sperm chromatin. Mol Reprod Dev 1997;47: 181-190.
69. Yang X, Khosravi-Far R, Chang HY, Baltimore D. Daxx, a novel fas-binding protein that activates jnk and apoptosis. Cell 1997;89: 1067-1076.
70. Drane P, Ouararhni K, Depaux A, Shuaib M, Hamiche A. The death-associated protein daxx is a novel histone chaperone involved in the replication-independent deposition of h3. 3. Genes Develop 2010;24: 1253-1265.
71. Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD. DAXX is an h3. 3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci U S A 2010;107: 14075-14080.
72. Hollenbach AD, McPherson CJ, Mientjes EJ, Iyengar R, Grosveld G. DAXX and histone deacetylase ii associate with chromatin through an interaction with core histones and the chromatin-associated protein DEK. J Cell Sci 2002;115: 3319-3330.
73. Kuo HY, Chang CC, Jeng JC, et al. Sumo modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of DAXX. Proc Natl Acad Sci U S A 2005;10247: 16973-16978.
74. Puto LA, Reed JC. Daxx represses relb target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Develop 2008;22: 998-1010.
75. Salomoni P, Khelifi AF. DAXX: Death or survival protein? Trends Cell Biol 2006;16: 97-104.
76. Goldberg AD, Banaszynski LA, Noh KM, et al. Distinct factors control histone variant h3. 3 localization at specific genomic regions. Cell 2010;140: 678-691.
77. Elsaesser SJ, Allis CD. HIRA and DAXX constitute two independent histone h3. 3-containing predeposition complexes. Cold Spring Harb Symp Quant Biol 2010;75: 27-34.
78. Schwartzentruber J, Korshunov A, Liu XY, et al. Driver mutations in histone h3. 3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012;482: 226-231.
79. Kamakaka RT, Biggins S. Histone variants: Deviants? Genes Develop 2005;19: 295-310.
80. Old RW, Woodland HR. Histone genes: Not so simple after all. Cell 1984;38: 624-626.
81. Henikoff S. Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet 2008;9: 15-26.
82. Jin C, Zang C, Wei G, et al. H3. 3/h2a. Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nat Genet 2009;41: 941-945.
83. Gessi M, Gielen GH, Hammes J, et al. H3. 3 g34r mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: Possible diagnostic and therapeutic implications? J Neurooncol 2013;112: 67-72.
84. Lal A, Pan Y, Navarro F, et al. Mir-24-mediated downregulation of h2ax suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol 2009;16: 492-498.
85. Bassett A, Cooper S, Wu C, Travers A. The folding and unfolding of eukaryotic chromatin. Curr Opin Genet Dev 2009;19: 159-165.
86. Kouzarides T. Chromatin modifications and their function. Cell 2007;128: 693-705.
87. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000;403: 41-45.
88. Lee JS, Smith E, Shilatifard A. The language of histone crosstalk. Cell 2010;142: 682-685.
89. Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, Allis CD. Synergistic coupling of histone h3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell 2000;5: 905-915.
90. Sassone-Corsi P, Mizzen CA, Cheung P, et al. Requirement of rsk-2 for epidermal growth factor-activated phosphorylation of histone h3. Science 1999;285: 886-891.
91. Thomson S, Clayton AL, Hazzalin CA, Rose S, Barratt MJ, Mahadevan LC. The nucleosomal response associated with immediate-early gene induction is mediated via alternative map kinase cascades: Msk1 as a potential histone h3/hmg-14 kinase. EMBO J 1999;18: 4779-4793.
92. Mahadevan LC, Willis AC, Barratt MJ. Rapid histone h3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 1991;65: 775-783.
93. Chadee DN, Hendzel MJ, Tylipski CP, et al. Increased ser-10 phosphorylation of histone h3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts. J Biol Chem 1999;274: 24914-24920.
94. Nowak SJ, Corces VG. Phosphorylation of histone h3 correlates with transcriptionally active loci. Genes Develop 2000;14: 3003-3013.
95. Crosio C, Fimia GM, Loury R, et al. Mitotic phosphorylation of histone h3: Spatio-temporal regulation by mammalian aurora kinases. Mol Cell Biol 2002;22: 874-885.
96. Crosio C, Cermakian N, Allis CD, Sassone-Corsi P. Light induces chromatin modification in cells of the mammalian circadian clock. Nat Neurosci 2000;3: 1241-1247.
97. Obrietan K, Impey S, Storm DR. Light and circadian rhythmicity regulate map kinase activation in the suprachiasmatic nuclei. Nat Neurosci 1998;1: 693-700.
98. Travnickova-Bendova Z, Cermakian N, Reppert SM, Sassone-Corsi P. Bimodal regulation of mperiod promoters by creb-dependent signaling and clock/bmal1 activity. Proc Natl Acad Sci U S A 2002;99: 7728-7733.
99. Goelet P, Castellucci VF, Schacher S, Kandel ER: The long and the short of long-term memory-a molecular framework. Nature 1986;322: 419-422.
100. Wisden W, Errington ML, Williams S, et al. Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron 1990;4: 603-614.
101. Selcher JC, Nekrasova T, Paylor R, Landreth GE, Sweatt JD. Mice lacking the erk1 isoform of map kinase are unimpaired in emotional learning. Learn Mem 2001;8: 11-19.
102. Rosenblum K, Futter M, Jones M, Hulme EC, Bliss TV. Erki/ii regulation by the muscarinic acetylcholine receptors in neurons. J Neurosci 2000;20: 977-985.
103. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007;447: 433-440.
104. Nestler EJ. Epigenetic mechanisms of drug addiction. Neuropharmacology 2013.
105. Camelo S, Iglesias AH, Hwang D, et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin a ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol 2005;164: 10-21.
106. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007;447: 425-432.
107. Pirooznia SK, Elefant F. Targeting specific hats for neurodegenerative disease treatment: Translating basic biology to therapeutic possibilities. Front Cell Neurosci 2013;7: 30.
108. Cao X, Sudhof TC. A transcriptionally [correction of transcriptively] active complex of app with fe65 and histone acetyltransferase tip60. Science 2001;293: 115-120.
109. Minopoli G, Gargiulo A, Parisi S, Russo T. Fe65 matters: New light on an old molecule. IUBMB Life 2012;64: 936-942.
110. Adamec E, Vonsattel JP, Nixon RA. DNA strand breaks in Alzheimer's disease. Brain Res 1999;849: 67-77.
111. Kim D, Frank CL, Dobbin MM, et al. Deregulation of HDAC1 by p25/CDK5 in neurotoxicity. Neuron 2008;60: 803-817.
112. Marambaud P, Wen PH, Dutt A, et al. A cbp binding transcriptional repressor produced by the PS1/epsilon-cleavage of n-cadherin is inhibited by PS1 FAD mutations. Cell 2003;114: 635-645.
113. Kim D, Nguyen MD, Dobbin MM, et al. Sirt1 deacetylase protects against neurodegeneration in models for alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 2007;26: 3169-3179.
114. Donmez G, Wang D, Cohen DE, Guarente L. Sirt1 suppresses beta-amyloid production by activating the alpha-secretase gene adam10. Cell 2010;142: 320-332.
115. Rouaux C, Jokic N, Mbebi C, Boutillier S, Loeffler JP, Boutillier AL. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 2003;22: 6537-6549.
116. Ricobaraza A, Cuadrado-Tejedor M, Perez-Mediavilla A, Frechilla D, Del Rio J, Garcia-Osta A. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an alzheimer's disease mouse model. Neuropsychopharmacology 2009;34: 1721-1732.
117. Kontopoulos E, Parvin JD, Feany MB. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet 2006;15: 3012-3023.
118. Outeiro TF, Kontopoulos E, Altmann SM, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of parkinson's disease. Science 2007;317: 516-519.
119. Chen PS, Wang CC, Bortner CD, et al. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 2007;149: 203-212.
120. Wang Y, Wang X, Liu L, Wang X. HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells. Neurosci Lett 2009;467: 212-216.
121. Zee BM, Levin RS, Xu B, LeRoy G, Wingreen NS, Garcia BA. In vivo residue-specific histone methylation dynamics. J Biol Chem 2010;285: 3341-3350.
122. Barth TK, Imhof A. Fast signals and slow marks: The dynamics of histone modifications. Trends Biochem Sci 2010;35: 618-626.
123. Peter CJ, Akbarian S. Balancing histone methylation activities in psychiatric disorders. Trends Mol Med 2011;17: 372-379.
124. Crosio C, Heitz E, Allis CD, Borrelli E, Sassone-Corsi P. Chromatin remodeling and neuronal response: Multiple signaling pathways induce specific histone h3 modifications and early gene expression in hippocampal neurons. J Cell Sci 2003;116: 4905-4914.
125. Hunter RG, Murakami G, Dewell S, et al. Acute stress and hippocampal histone H3 lysine 9 trimethylation, a retrotransposon silencing response. Proc Natl Acad Sci U S A 2012;109: 17657-17662.
126. Hunter RG, McCarthy KJ, Milne TA, Pfaff DW, McEwen BS. Regulation of hippocampal h3 histone methylation by acute and chronic stress. Proc Natl Acad Sci U S A 2009;106: 20912-20917.
127. Birney E, Stamatoyannopoulos JA, Dutta A, et al. Identification and analysis of functional elements in 1% of the human genome by the encode pilot project. Nature 2007;447: 799-816.
128. Kazazian HH, Jr, Goodier JL. Line drive. Retrotransposition and genome instability. Cell 2002;110: 277-280.
129. Perron H, Lang A. The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation. Clin Rev Allergy Immunol 2010;39: 51-61.
130. Ponicsan SL, Kugel JF, Goodrich JA. Genomic gems: Sine RNAs regulate mRNA production. Curr Opin Genet Dev 2010;20: 149-155.
131. Muotri AR, Marchetto MC, Coufal NG, et al. L1 retrotransposition in neurons is modulated by mecp2. Nature 2010;468: 443-446.
132. Ryu H, Lee J, Hagerty SW, et al. Eset/setdb1 gene expression and histone h3 (k9) trimethylation in huntington's disease. Proc Natl Acad Sci U S A 2006;103: 19176-19181.
133. Rea S, Eisenhaber F, O'Carroll D, et al. Regulation of chromatin structure by site-specific histone h3 methyltransferases. Nature 2000;406: 593-599.
134. Hu Y, Chopra V, Chopra R, et al. Transcriptional modulator h2a histone family, member y (h2afy) marks huntington disease activity in man and mouse. Proc Natl Acad Sci U S A 2011;108: 17141-17146.
135. Stack EC, Del Signore SJ, Luthi-Carter R, et al. Modulation of nucleosome dynamics in huntington's disease. Hum Mol Genet 2007;16: 1164-1175.
136. Ayyanathan K, Lechner MS, Bell P, et al. Regulated recruitment of hp1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: A mammalian cell culture model of gene variegation. Genes Develop 2003;17: 1855-1869.
137. Jakobsson J, Cordero MI, Bisaz R, et al. Kap1-mediated epigenetic repression in the forebrain modulates behavioral vulnerability to stress. Neuron 2008;60: 818-831.
138. Jiang Y, Jakovcevski M, Bharadwaj R, et al. SETDB1 histone methyltransferase regulates mood-related behaviors and expression of the nmda receptor subunit NR2B. J Neurosci 2010;30: 7152-7167.
139. Penner MR, Roth TL, Chawla MK, et al. Age-related changes in arc transcription and DNA methylation within the hippocampus. Neurobiol Aging 2011;32: 2198-2210.
140. Peters AH, Schubeler D. Methylation of histones: Playing memory with DNA. Curr Opin Cell Biol 2005;17: 230-238.
141. Gupta-Agarwal S, Franklin AV, Deramus T, et al. G9a/glp histone lysine dimethyltransferase complex activity in the hippocampus and the entorhinal cortex is required for gene activation and silencing during memory consolidation. J Neurosci 2012;32: 5440-5453.
142. Shinkai Y, Tachibana M: H3k9 methyltransferase G9a and the related molecule GLP. Genes Develop 2011;25: 781-788.
143. Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005;6: 838-849.